Biochemistry
Biochemistry
Biochemistry
SYLLABUS
Cellular Respiration/Oxidation: (P. 1029)
Biological oxido-reduction: mechanism, examples
Citric acid cycle (P. 1029): feeder pathways (P. 1029), pathways leading form, Overview of reactions,
regulation (P. 1031), amphibolism (P. 1031) and clinical application (P. 1031), energetics of TCA (P. 1031)
Electron transport chain: (P. 1032)
Cellular location, channeling of reducing equivalents (P. 1033), mechanism of ATP synthesis (P. 1033)
Oxidative phosphorylation: (P. 1034)
Chemiosmotic theory (P. 1035), clinical application of inhibitors / uncouplers (P. 1036)
Brown adipose tissue energy metabolism (P. 1037), thermogenin (P. 1037)
Oxidative Stress and Antioxidant Systems: (P. 1037)
Free redical (P. 1037), sources of free radicals, antioxidant systems (P. 1038), other biological anti-oxidants,
failure of antioxidant systems- clinical implications (P. 1039)
Vitamin E: (P. 1039)
Dietary sources, metabolism and antioxidant function (P. 1040) IV
IV
BIOCHEMISTRY
IV
This is due to fact that unless sufficient level iii. Mitochondrial citrate is transported to the
of ADP are available, oxidation (coupled cytosol, where it is cleaved to provide acetyl
with phosphorylation of ADP to ATP) of COA for the biosynthesis of fatty acids,
NADH and FADH2 through ETC stops. sterols etc.
- The high energy compounds such as Three possible sites of action for inhibiters of ETC
phosphoenolpyruvate and 1,3 are as follow
bisphosphoglycerate (intermediates of Sites Inhibitor
glycolysis) and succinyl CoA (intermediate of
1. NADH and Fish poison, rotenone,
TCA cycle) can transfer high energy
coenzyme Q barbiturate drug amytal and
phosphates to ultimately to produce ATP.
antibiotic piercidin A
Inhibitor of ETC [03,05]
2. Between cyt band C1 Antimycin A, British
The inhibitors bind to one of the compoment of antilewisite (BAL)
ETC and block the transport of electrons.
3. Cytochrome oxidase Carbonmonoxide, cyanide,
This causes the accumulation of reduced hydrogen sulphide, and azide
components before the inhibitor blockade step
and oxidized component after that step.
IV
IV
IV
Respiratory acidosis [11, 06, 05, 04] Blood gas analysis
- Respiratory acidosis occurs when there is pH PCO2 HCO3–
accumulation of CO2 due to reduced effective
Acute resp. acidosis Normal or
alveolar ventilation.
- Ratio of bicarbonate to carbonic acid: less than Chronic acidosis
20 Compensatory mechanism
Cause - Excess carbonic acid is buffered by hemoglobin
i. Airway obstruction: COPD, bronchospasm, and protein buffer system.
asthma, pneumothorax - Kidney responds by conserving HCO3- and
ii. Depression of respiratory centre: Anaesthesia, excreting H+ as NH4+.
sedative, cerebral trauma, tumors, narcotics Clinical features
iii. Neuromuscular disease: Poliomyelitis, tetanus, - Decreased respiratory rate, hypotension and
motor neuron disease coma.
iv. Pulmonary disease: Pulmonary fibrosis, - Dominated by the cause of hypoventilation (eg.
Pneumonia paralysis, chest wall injury, chronic obstructive
v. CNS trauma, tumor lungs disease)
vi. Ascites, peritonitis - CO2 accumulation leads to drowsiness,
peripheral vasodilation, tachycardia and
vii. Sleep apnea
tremors.
IV
4. Vitamin E
- Vitamin E is least toxic fat soluble vitamin.
- Vitamin E is the most powerful anti-oxidant.
- Selenium has to be found to decrease the requirement of Vitamin E and vice versa.
- Requirement increases as the intake of poly unsaturated fatty acid (PUFA) increases.
- It is stored in the adipose tissue.
- It is absorbed along with fatty acids with the help of bile salts.
- Dose above 1000 IU per day cause hypervitaminosis.